{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T06:50:01Z","timestamp":1707288601144},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6629","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T18:16:34Z","timestamp":1475259394000},"page":"2855-2859","source":"Crossref","is-referenced-by-count":4,"title":["Drug-induced Pneumonitis Following the Administration of TAS-102"],"prefix":"10.2169","volume":"55","author":[{"given":"Yoshikazu","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Izumi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayo","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Izumi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsukuda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Izumi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Suzumura","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Izumi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Izumi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yoshino T, Mizunuma N, Yamazaki K, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 13: 993-1001, 2012.","DOI":"10.1016\/S1470-2045(12)70345-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mayer RJ, Van Cutsem E, Falcone A, et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med 372: 1909-1919, 2015.","DOI":"10.1056\/NEJMoa1414325"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kubo K, Azuma A, Kanazawa M, et al. Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respir Investig 51: 260-277, 2013.","DOI":"10.1016\/j.resinv.2013.09.001"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59: 809-820, 2004.","DOI":"10.1111\/j.1398-9995.2004.00547.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Matsuno O. Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res 13: 39, 2012.","DOI":"10.1186\/1465-9921-13-39"},{"key":"6","unstructured":"6. Kawabata R, Koida M, Kanie S, Tanaka G, Ohuchida A, Yoshida T. DLST as a method for detecting TS-1-induced allergy. Gan To Kagaku Ryoho (Japanese Journal of Cancer and Chemotherapy) 33: 345-348, 2006 (in Japanese, Abstract in English)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tanaka N, Sakamoto K, Okabe H, et al. Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models. Oncol Rep 32: 2319-2326, 2014.","DOI":"10.3892\/or.2014.3487"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Karageorgopoulos DE, Qu JM, Korbila IP, Zhu YG, Vasileiou VA, Falagas ME. Accuracy of \u03b2-D-glucan for the diagnosis of <i>Pneumocystis jirovecii<\/i> pneumonia: a meta-analysis. Clin Microbiol Infect 19: 39-49, 2013.","DOI":"10.1111\/j.1469-0691.2011.03760.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of serum 1,3-\u03b2-D-glucan for <i>Pneumocystis jiroveci<\/i> pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50: 7-15, 2012.","DOI":"10.1128\/JCM.05267-11"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 131: 1173-1180, 2007.","DOI":"10.1378\/chest.06-1467"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Varthalitis I, Aoun M, Daneau D, Meunier F. <i>Pneumocystis carinii<\/i> pneumonia in patients with cancer. An increasing incidence. Cancer 71: 481-485, 1993.","DOI":"10.1002\/1097-0142(19930115)71:2<481::AID-CNCR2820710232>3.0.CO;2-S"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mori H, Ohno Y, Ito F, et al. Polymerase chain reaction positivity of <i>Pneumocystis jirovecii<\/i> during primary lung cancer treatment. Jpn J Clin Oncol 40: 658-662, 2010.","DOI":"10.1093\/jjco\/hyq040"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 34: 1098-1107, 2002.","DOI":"10.1086\/339548"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yano S. S-1-induced lung injury combined with pneumocystis pneumonia. BMJ Case Rep 2013: 2013.","DOI":"10.1136\/bcr-2012-008171"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/19\/55_55.6629\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T01:05:24Z","timestamp":1568423124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/19\/55_55.6629\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":14,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6629","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}